Precision oncology represents a transformative approach in cancer treatment, tailored to the individual genetic profile of each patient. This innovative method leverages advancements in genomic technologies to target cancer more accurately and effectively than traditional treatments. As of 2023, the precision oncology market was valued at USD 107.82 billion, driven by its increasing recognition...